Single CRISPR treatment provides long-term benefits in mice

(Duke University) Researchers at Duke University have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease -- Duchenne muscular dystrophy (DMD) -- for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news